Glenn Greenberg
Brave Warrior Advisors
Brave Warrior Advisors Portfolio 13F
Glenn Greenberg Holdings Activity
- Portfolio value:
- $2.48B≈ (+$5M≈)
- Previous value:
- $2.47B≈
- # of changes:
- 10
- New positions:
- 1
- Reported for:
- 30 Jun 2014 (Q2)
- Latest filing date:
- 14 Aug 2014
Brave Warrior Advisors has disclosed a total of 10 changes to the portfolio in the (2014 Q2) SEC report(s): increased the number of shares of 6, bought 1 totally new and decreased the number of shares of 3 position(s).
What stocks did Glenn Greenberg buy in 2014 Q2?
During 2014 Q2 Glenn Greenberg has bought 7 securities out of which top 5 purchases (by % change to portfolio) were (VRX) Valeant Pharmaceuticals International Inc (added shares +8.19%), (ESRX) Express Scripts Holding Co (added shares +31.94%), (ORCL) Oracle Corp (added shares +1.12%), (SCHW) Charles Schwab Corp (added shares +15.79%) and (MSFT) Microsoft Corp (added shares +21.45%).
What did Glenn Greenberg invest in during 2014 Q2?
In the 2014 Q2 report(s) the following changes have been made to the top investments: (VRX) Valeant Pharmaceuticals International Inc (added shares +8.19%), (ESRX) Express Scripts Holding Co (added shares +31.94%), (ORCL) Oracle Corp (added shares +1.12%), (SCHW) Charles Schwab Corp (added shares +15.79%) and (KMR) KINDER MORGAN MANAGEMENT LLC (reduced shares -12.98%).
10 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Equinix Inc
|
new
|
$203.77
|
+413.57%($1,046.51)
|
4.32%
|
2014 Q2
|
≈ 0.25 years
|
||||
|
|
Express Scripts Holding Co
|
+31.94%
|
$69.33
|
|
13.08%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
Microsoft Corp
|
+21.45%
|
$41.70
|
+840.20%($392.06)
|
8.14%
|
2013 Q3
|
≈ 1.00 year
|
||||
|
|
Charles Schwab Corp
|
+15.79%
|
$26.93
|
+286.15%($103.99)
|
9.07%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
VISTAPRINT NV ORD SHS (NL)
|
+14.26%
|
$40.46
|
|
5.92%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
Valeant Pharmaceuticals International Inc
|
+8.19%
|
$126.12
|
|
30.78%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
Oracle Corp
|
+1.12%
|
$40.53
|
+196.47%($120.16)
|
12.90%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
Primerica Inc
|
-0.54%
|
$47.85
|
+559.10%($315.38)
|
6.48%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
KINDER MORGAN MANAGEMENT LLC
|
-12.98%
|
$78.93
|
|
9.03%
|
2013 Q4
|
≈ 0.75 years
|
||||
|
|
Halliburton Company
|
-98.26%
|
$71.01
|
-54.14%($32.56)
|
0.20%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.